Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumorAndrew M. Fleming, Andrew J. Murphy, John Easton et al.|Cell Reports|2026Cited by 1
Supplemental Figure 2 from Tandem Duplications in <i>UBTF</i> Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic DependencyJuan M. Barajas, Jeffery M. Klco, Aaron H. Phillips et al.|Unknown|2026Cited by 0
Supplemental Figure 4 from Tandem Duplications in <i>UBTF</i> Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic DependencyJuan M. Barajas, Jeffery M. Klco, Aaron H. Phillips et al.|Unknown|2026Cited by 0
Supplemental Figure 8 from Tandem Duplications in <i>UBTF</i> Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic DependencyJuan M. Barajas, Jeffery M. Klco, Aaron H. Phillips et al.|Unknown|2026Cited by 0
Data from Tandem Duplications in <i>UBTF</i> Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic DependencyJuan M. Barajas, Jeffery M. Klco, Aaron H. Phillips et al.|Unknown|2026Cited by 0